Abstract

Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt

Author(s): Pramar Yashoda V, Mandal Tarum K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A

Issue: Mar/Apr 2023 - Volume 27, Number 2

Page(s): 160-168

Download in electronic PDF format for $75
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 1
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 2
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 3
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 4
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 5
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 6
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 7
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 8
  • Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Page 9

Abstract

Pyrimethamine is an antiparasitic compound available only in tablet form for oral administration. A review of the therapeutic uses of pyrimethamine reveals the need for flexibility in dosing. This flexibility is readily achieved using an oral liquid dosage form. However, no commercial liquid dosage form of pyrimethamine currently exists. Pyrimethamine is available commercially only as 25-mg tablets. An extemporaneously compounded suspension from pure drug powder would provide a flexible, customizable option to meet unique patient needs with convenient and accurate dosing options. The purpose of this study was to determine the physicochemical and microbiological stability of extemporaneously compounded pyrimethamine suspension in PCCA Base, SuspendIt. This base is a sugar-free, paraben-free, dye-free, and gluten-free thixotropic vehicle containing a natural sweetener obtained from the monk fruit. A robust stability-indicating high-performance liquid chromatographic assay for the determination of the chemical stability of pyrimethamine in PCCA SuspendIt was developed and validated. Suspensions of pyrimethamine were prepared in PCCA SuspendIt at a 2-mg/mL concentration, selected to provide flexibility in customizing individual doses. Samples were stored in amber plastic prescription bottles at two temperature conditions (5°C and 25°C). Samples were assayed initially, and on the following time points (days): 7, 14, 28, and 42. Physical data such as pH, viscosity, and appearance were also noted. Microbiological stability was tested. All measurements were obtained in triplicate. A stable extemporaneous product is defined as one that retains at least 90% of the initial drug concentration throughout the sampling period and is protected against microbial growth. The study showed that pyrimethamine concentrations did not go below 96% of the label claim (initial drug concentration) at both temperatures studied. No microbial growth was observed. pH values remained constant. The viscosity of the suspensions allowed easy re-dispersal of the drug particles upon shaking. This study demonstrates that pyrimethamine is physically, chemically, and microbiologically stable in PCCA SuspendIt for 42 days stored in the refrigerator and at room temperature, thus providing a viable, compounded alternative for pyrimethamine in a liquid dosage form.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2023
Pg. 160-168
Jul/Aug 2022
Pg. 342-351
Sep/Oct 2021
Pg. 431-439
Jul/Aug 2024
Pg. 334-343
Sep/Oct 2014
Pg. 427-431
Mar/Apr 2021
Pg. 169-175
Jul/Aug 2023
Pg. 330-339
Mar/Apr 2019
Pg. 157-162
Sep/Oct 2020
Pg. 413-419
May/Jun 2018
Pg. 240-246
Jul/Aug 2017
Pg. 334-338
Nov/Dec 2019
Pg. 519-527
May/Jun 2007
Pg. 259-261
Author(s): Gupta Vishnu D
Jul/Aug 2022
Pg. 330-335
Jul/Aug 2024
Pg. 321-328
Jul/Aug 2008
Pg. 372-374
Author(s): Gupta Vishnu D
Jul/Aug 2017
Pg. 322-329
Jan/Feb 2019
Pg. 70-76
Jan/Feb 2011
Pg. 78-80
Jan/Feb 2023
Pg. 72-77